Multiple Sclerosis and Related Disorders

Multiple Sclerosis and Related Disorders

Is long-term teriflunomide treatment safe in MS? 2:13
Is long-term teriflunomide treatment safe in MS?
Mark Freedman • 3 Mar 2021
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML 2:14
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Claire Riley • 26 Feb 2021
Immunomodulatory effects of vitamin D in MS 3:13
Immunomodulatory effects of vitamin D in MS
Jorge Correale • 5 Mar 2021
Assessing cognitive fatigability in MS 2:47
Assessing cognitive fatigability in MS
Mark Freedman • 3 Mar 2021
Moving forward in progressive MS 0:49
Moving forward in progressive MS
Claire Riley • 26 Feb 2021
VISIONARY-MS: pure gold nanocrystals for neurorepair and neuroprotection in MS 4:51
VISIONARY-MS: pure gold nanocrystals for neurorepair and neuroprotection in MS
Robert Glanzman • 1 Mar 2021
What’s to come in the MS field? 1:04
What’s to come in the MS field?
Carlos Pérez • 25 Feb 2021
Investigating remyelination with apo-transferrin and triiodothyronine 3:07
Investigating remyelination with apo-transferrin and triiodothyronine
Jorge Correale • 5 Mar 2021
Highlights from ACTRIMS Forum 2021 2:16
Highlights from ACTRIMS Forum 2021
Rhonda Voskuhl • 25 Feb 2021
Addressing unmet needs in MS: progressive disease and damage repair 3:18
Addressing unmet needs in MS: progressive disease and damage repair
Amit Bar-Or • 25 Feb 2021
Can gold-based nanotechnology meet the need for neuro-reparative therapies in MS? 1:43
Can gold-based nanotechnology meet the need for neuro-reparative therapies in MS?
Robert Glanzman • 1 Mar 2021
Detecting MS progression with a wearable multisensor device 2:20
Detecting MS progression with a wearable multisensor device
Jennifer Graves • 27 Feb 2021
Benign and aggressive MS: nature or nurture? 3:34
Benign and aggressive MS: nature or nurture?
Mark Freedman • 3 Mar 2021
Leptin promotes inflammatory responses in obese MS patients 5:31
Leptin promotes inflammatory responses in obese MS patients
Jorge Correale • 5 Mar 2021
Adiponectin induces pro-inflammatory immune activation in pediatric-onset MS 3:11
Adiponectin induces pro-inflammatory immune activation in pediatric-onset MS
Amit Bar-Or • 25 Feb 2021
Exploring the protective nature of pregnancy in MS 1:16
Exploring the protective nature of pregnancy in MS
Jennifer Graves • 27 Feb 2021
The content of VJNeurology is intended for healthcare professionals